Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin vs Oxytocin for Postpartum Hemorrhage Prevention
NCT04201665Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Sep 2020
- Primary completion
- Jan 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Power density spectrum peak frequency of uterine EMG bursts at 3 hours. Started Sep 2020; status: completed.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT04201665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04201665.